Tag: interferon
Alemtuzumab vs interferon in relapsing remitting MS
Study shows that alemtuzumab is more effective than interferon in reducing disease activity in relapsing remitting MS
Improving fatigue by doing exercise
New evidence that exercise could reduce patients’ blood interferon level and fatigue
Switching to second-line disease-modifying drugs
Study shows that switching to natalizumab is more effective than switching to fingolimod
Disease-modifying drugs may reduce disability progression in relapsing-remitting MS
Researchers found a lower risk of disability progression at the 10-year follow-up in the RRMS group compared with historical cohorts
Positive outcomes in changing from interferon to glatiramer acetate
Switching patients with relapsing-remitting MS from interferon to glatiramer acetateis associated with positive treatment outcomes